Clinical trial
Survival and Axillary Recurrence Following Sentinel Node-positive Breast Cancer Without Completion Axillary Lymph Node Dissection - a Randomized Study of Patients With Macrometastases in the Sentinel Node
NCT02240472 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Survival and Axillary Recurrence Following Sentinel Node-positive Breast Cancer Without Completion Axillary Lymph Node Dissection - a Randomized Study of Patients With Macrometastases in the Sentinel Node
- Lead sponsor
- Karolinska Institutet
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 27, 2015
- Completion date
- December 31, 2031
- Enrollment
- 2,766 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer